Workflow
Securities and investment fraud
icon
Search documents
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-07-08 02:59
Company Overview - PetMed Express, Inc. is an online pet pharmacy that provides prescription and non-prescription medications, supplements, and pet supplies directly to consumers across the United States [3]. Allegations and Stock Impact - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 earnings due to the need for additional time to complete its year-end audit process, resulting in a stock price decline of $0.47, or 11.2%, closing at $3.72 per share on June 11, 2025 [3]. - On July 1, 2025, PetMed disclosed another delay in filing its annual report with the SEC, linked to an internal investigation by the Audit Committee regarding whistleblower complaints about revenue recognition, promotional coupon impacts, and company culture. This announcement led to a further stock price drop of $0.05, or 1.51%, closing at $3.27 per share on the same day [3]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed, stemming from allegations of providing misleading business information to investors [1].
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of SelectQuote, Inc. (NYSE: SLQT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-06-06 21:42
Company Overview - SelectQuote is a direct-to-consumer insurance platform that offers health, life, auto, and home insurance policies, as well as medication management services through its SelectRx pharmacy division [3] Allegations and Legal Issues - The Department of Justice filed a False Claims Act complaint against SelectQuote on May 1, 2025, alleging the company received millions of dollars in kickbacks from Humana in exchange for specific Medicare Advantage plan enrollments [4] - The complaint claims SelectQuote maintained a sales division that exclusively offered Humana policies and directed a significant portion of its business to Humana [4] Market Reaction - Following the filing of the complaint, SelectQuote's stock price fell by $0.61 per share, or 19.2%, closing at $2.56 per share on May 1, 2025 [5]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Luminar Technologies, Inc. (NASDAQ: LAZR) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Prnewswire· 2025-06-05 01:26
Company Overview - Luminar Technologies is an automotive technology company focused on developing advanced sensors, software, and safety systems for autonomous vehicles [3] Allegations and Impact - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Luminar, stemming from allegations of providing misleading business information to investors [1] - On May 14, 2025, Luminar announced the resignation of its founder, President, and CEO Austin Russell, due to a business conduct and ethics inquiry by an internal audit committee [4] - Following the announcement of Russell's resignation, Luminar's stock price dropped by $0.80 per share, or 16.81%, closing at $3.96 per share on May 15, 2025 [4]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. (NASDAQ: FLGT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-05-28 22:10
Company Overview - Fulgent Genetics, Inc. is a biotechnology company that specializes in diagnostic and genetic laboratory testing services and develops pharmaceutical treatments for various diseases and medical conditions [3] Allegations and Investigations - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Fulgent, stemming from allegations of providing potentially misleading business information to investors [1] - On February 28, 2025, Fulgent disclosed in its annual report that it received a civil investigative demand from the U.S. Department of Justice related to potential false claims submitted under the federal COVID-19 testing program for uninsured individuals [4] Market Reaction - Following the disclosure of the civil investigative demand, Fulgent's stock price declined by $0.41 per share, or approximately 2.61%, closing at $15.28 per share on March 3, 2025 [5]
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of New Fortress Energy, Inc. (NASDAQ: NFE) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
GlobeNewswire News Room· 2025-05-28 21:38
Company Overview - New Fortress Energy, Inc. is an energy company that develops, finances, and operates liquefied natural gas (LNG) facilities and power plants globally [3] - The company operates through two segments: "Terminals and Infrastructure," focusing on LNG production and distribution, and "Ships," which provides LNG storage and transportation services [3] Allegations and Financial Performance - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving New Fortress due to allegations of providing misleading business information to investors [1] - On May 14, 2025, New Fortress announced its financial results for Q1 2025, reporting a total revenue decline of $219.8 million compared to Q1 2024, resulting in a net loss of $197.4 million, down from a net income of $56.7 million in the same quarter of the previous year [4] - Following the financial announcement, New Fortress' stock price fell by $4.27 per share, approximately 62.98%, closing at $4.27 on May 15, 2025 [5]